Real-world Study Shows Lab-made Kovaltry Works Better for Hem A
Patients with hemophilia A who switched to Kovaltry (octocog alfa) — a recombinant, or lab-made, factor VIII (rFVIII)…
Articles by Vanda Pinto, PhD
Prophylaxis May Help to Preserve Bone Mineral Density in Children
Bone mineral density — the amount of minerals in bone tissue — is markedly lower in children with moderate and…
WFH Celebrates Milestone in Distributing Bleeding Disorder Therapies
The World Federation of Hemophilia (WFH) is commemorating having successfully distributed, since 1996, over one billion international units (IUs)…
Sexual Problems Nearly 4 Times More Likely for Hemophilia Patients
People with hemophilia are nearly four times more likely to experience sexual problems than are individuals without bleeding disorders, according…
HFA Tackles Mental Health ‘Head-on’ With New Well-being Courses
The Hemophilia Federation of America (HFA) is now offering mental health and well-being courses, through its Learning Central program,…
Phase 4 Trial of Ixinity for Pediatric Hemophilia B Is Fully Enrolled
Medexus Pharmaceuticals has completed patient enrollment in its clinical trial investigating Ixinity as a preventive treatment for children younger…
Injection Therapy Like Hemlibra Favored Over Infusions by Adults
Adults across the general public in Canada think an under-the-skin injection treatment for hemophilia A would be preferable to…
COVID-19 May Trigger Acquired Hemophilia A, Case Study Says
SARS-CoV-2, the virus that causes COVID-19, might have triggered acquired hemophilia A (AHA) in a 65-year-old man with a…
Quality of Life Benefits Seen With Long-term Hemlibra Use in Trials
Preventive treatment with Hemlibra (emicizumab) sustainably improved physical health-related quality of life and led to fewer missed workdays among…
Elective Surgery Safe in Australia for Hemophilia, Bleeding Disorders
Complication rates for elective surgeries in people with inherited bleeding disorders like hemophilia are low in Australia, reflecting good safety in…